# Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

> **NCT02814708** · PHASE2 · COMPLETED · sponsor: **Biomedizinische Forschungs gmbH** · enrollment: 140 (actual)

## Conditions studied

- Toxic Shock Syndrome

## Interventions

- **BIOLOGICAL:** rTSST-1v

## Key facts

- **NCT ID:** NCT02814708
- **Lead sponsor:** Biomedizinische Forschungs gmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-05
- **Final completion:** 2021-01
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814708, "Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02814708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*